Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

ISR
IsoRay, Inc.
stock NYSEAMERICAN

Inactive
May 23, 2025
530.75USD+138116.146%(+530.37)420
Pre-market
0.00USD-100.000%(-0.38)0
After-hours
0.00USD0.000%(0.00)0
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 26, 2022
08:10AM EST  Isoray To Announce Second Quarter Fiscal 2022 Financial Results on   GlobeNewswire Inc
Dec 14, 2021
10:36AM EST  '#Isoray's Cesium-131 #brachytherapy is being used to treat some recurrent #braincancer tumors. See how @JohnsHopkins treated this patient's stubborn metastatic brain tumor...' -Tweet From IsoRay   Benzinga
Nov 10, 2021
05:42PM EST  IsoRay Q1 EPS $(0.02) Misses $(0.01) Estimate, Sales $2.56M Beat $2.49M Estimate   Benzinga
04:09AM EST  Earnings Scheduled For November 10, 2021   Benzinga
Oct 29, 2021
08:13AM EDT  Isoray To Announce First Quarter Fiscal 2022 Financial Results on   GlobeNewswire Inc
Oct 25, 2021
07:00AM EDT  The following are some of the stocks making big moves in Monday's pre-market trading (as of 06.25 A.M. EDT).   RTTNews
Sep 28, 2021
08:13AM EDT  American Brachytherapy Society LDR Prostate Brachytherapy   GlobeNewswire Inc
Sep 23, 2021
07:24AM EDT  Recap: Isoray Q4 Earnings   Benzinga
Sep 21, 2021
06:59PM EDT  Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in brachytherapy powering expanding treatment options throughout the body, will host a rescheduled conference call to discuss its financial results for the fourth quarter and fiscal year ended June 30, 2021 on Wednesday, September 22, 2021, at 10:00 a.m. Eastern Time/7:00 a.m. Pacific.   GlobeNewswire Inc
04:07PM EDT  IsoRay Q4 EPS $(0.01), Inline, Sales $2.71M Miss $2.75M Estimate   Benzinga
04:05PM EDT  Record Full Year RevenueFiscal Fourth Quarter Revenue Increased 19% Year-Over-Year   GlobeNewswire Inc
04:02AM EDT  Earnings Scheduled For September 21, 2021   Benzinga
Sep 15, 2021
05:23PM EDT  Isoray 8-K Shows Co.'s Isoray Medical Unit Entered Consignment Deal With MedikorPharma-Ural For Supply Of Ceisum-131   Benzinga
Sep 14, 2021
10:16AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2021   Benzinga
08:22AM EDT  Northland Capital Markets Initiates Coverage On Isoray with Outperform Rating, Announces Price Target of $1.25   Benzinga
Sep 9, 2021
08:13AM EDT  Isoray To Announce Fourth Quarter and Fiscal Year End   GlobeNewswire Inc
May 24, 2021
11:04AM EDT  Return On Capital Employed Overview: IsoRay   Benzinga
May 13, 2021
04:34PM EDT  IsoRay Q3 EPS $(0.01), Inline, Sales $2.60M Beat $2.43M Estimate   Benzinga
04:05PM EDT  Revenue Increased 10% SequentiallyRecord Non-Prostate Brachytherapy Revenue Increased 20% Year-Over-Year   GlobeNewswire Inc
04:15AM EDT  Earnings Scheduled For May 13, 2021   Benzinga
Apr 29, 2021
08:13AM EDT  Isoray To Announce Third Quarter Fiscal 2021Financial   GlobeNewswire Inc
Apr 13, 2021
08:13AM EDT  Isoray, Inc. (NYSE American: ISR), a medical technology company and seed brachytherapy innovator, today announced that Donna Fort has been appointed Vice President, Sales and Marketing.   GlobeNewswire Inc
Mar 31, 2021
10:12AM EDT  IsoRay's Cesium-131 And Surgical Resection Shows Promise In Recurrent Head & Neck Cancer   Benzinga
08:13AM EDT  A recently published small prospective series of patients with recurrent head and neck (H&N) cancers treated with surgical resection and Isorays Cesium-131 brachytherapy found potential benefits that support further research into combination therapy with Cesium-131 brachytherapy and surgical resection.   GlobeNewswire Inc
Mar 3, 2021
08:13AM EST  Isoray to Present at the Oppenheimer 31st Annual Healthcare Conference   GlobeNewswire Inc
Feb 17, 2021
09:37AM EST  ROCE Insights For IsoRay   Benzinga
Feb 16, 2021
08:13AM EST  Isoray, Inc. (NYSE American: ISR), a medical technology company and seed brachytherapy innovator, today announced that Lisa Lauer has been appointed Vice President, Business Development.   GlobeNewswire Inc
Feb 10, 2021
06:12AM EST  HC Wainwright & Co. Maintains Buy on Isoray, Raises Price Target to $2.1   Benzinga
Feb 9, 2021
04:25PM EST  IsoRay Q2 EPS $(0.01), Inline, Sales $2.36M Miss $2.39M Estimate   Benzinga
04:06PM EST  Revenue Increased 7% Year-Over-YearNon-Prostate Brachytherapy Revenue Increased 92% Year-Over-Year   GlobeNewswire Inc
04:05AM EST  Earnings Scheduled For February 9, 2021   Benzinga
Feb 5, 2021
08:13AM EST  Isoray To Announce Second Quarter Fiscal 2021 Financial Results on   GlobeNewswire Inc
Feb 4, 2021
08:32AM EST  Isoray Prices 36M hare Common Stock Offering At $1.25/Share   Benzinga
08:30AM EST  Isoray Announces Pricing of $45 Million Public Offering   GlobeNewswire Inc
Feb 3, 2021
04:30PM EST  Isoray Sees Prelim. Q2 Sales $2.36M vs $2.39M Est.   Benzinga
04:03PM EST  Isoray Reports Common Stock Offering, No Size Disclosed   Benzinga
04:01PM EST  Isoray Announces Proposed Underwritten Public Offering   GlobeNewswire Inc
Jan 7, 2021
08:13AM EST  Isoray, Inc. (NYSE American: ISR), a medical technology company and seed brachytherapy innovator powering expanding treatment options throughout the body, today announced that Chief Executive Officer Lori Woods will present at the H.C. Wainwright BioConnect 2021 Conference. The virtual conference will be held January 11-14, 2021.   GlobeNewswire Inc
Jan 6, 2021
02:34PM EST  Mid-Afternoon Market Update: Dow Surges Over 600 Points; Imara Shares Plunge   Benzinga
12:24PM EST  Mid-Day Market Update: Gold Down Over 2%; Change Healthcare Shares Jump   Benzinga
10:02AM EST  Looking Into IsoRay's Return On Capital Employed   Benzinga
Jan 5, 2021
04:58PM EST  C4 Imaging Announces Sirius Positive Signal Mri Marker Given Fda 510 Clearance For Use With Isoray's Cesium-131 Brachytherapy Seeds To Treat Prostate Cancer   Benzinga
04:55PM EST  C4 Imaging LLC is pleased to announce that Isoray Medical, Inc. (NYSE American: ISR) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the use of C4 Imagings Siriuspositive-signal MRI (Magnetic Resonance Imaging) Markers with Isorays Cesium-131, brachytherapy seeds.   GlobeNewswire Inc
Dec 16, 2020
10:41AM EST  Oppenheimer Initiates Coverage On Isoray with Outperform Rating, Announces Price Target of $1   Benzinga
Nov 24, 2020
08:19AM EST  Isoray Highlights Mention Of Cesium-131 In Multiple Presentations At ASTRO   Benzinga
08:13AM EST  Isorays Cesium-131 Spotlighted in Multiple   GlobeNewswire Inc
Nov 10, 2020
04:32PM EST  IsoRay Q1 EPS $(0.01), Inline, Sales $2.38M Miss $2.85M Estimate   Benzinga
04:05PM EST  Isoray Announces First Quarter Fiscal 2021 Financial Results   GlobeNewswire Inc
Nov 9, 2020
10:21AM EST  Earnings Preview for IsoRay   Benzinga
Nov 2, 2020
08:13AM EST  Isoray To Announce First Quarter Fiscal 2021 Financial Results on   GlobeNewswire Inc
Oct 28, 2020
04:40PM EDT  Isoray CEO Woods Buys 72,114 @ Avg Price: $0.35   Benzinga
Oct 20, 2020
02:34PM EDT  Mid-Afternoon Market Update: Dow Rises 1%; Aptinyx Shares Spike Higher   Benzinga
12:12PM EDT  Mid-Day Market Update: Cleveland BioLabs Jumps On Merger News; Isoray Shares Slide   Benzinga
09:16AM EDT  Isoray Reports Pricing Of $9.5 Mln Public Offering   RTTNews
09:06AM EDT  Isoray Prices ~18.269M Share Common Stock Offering At $0.52/Unit   Benzinga
09:00AM EDT  Isoray, Inc. Announces Pricing of $9.5 Million Public Offering   GlobeNewswire Inc
Oct 19, 2020
05:17PM EDT  10 Stocks Moving In Monday's After Hours Session   Benzinga
04:57PM EDT  Isoray Reports Offering Of Common Stock, No Size Disclosed   Benzinga
04:56PM EDT  Isoray, Inc. Announces Proposed Underwritten Public Offering   GlobeNewswire Inc
04:11PM EDT  IsoRay Inc Says On October 19 Terminated Equity Distribution Agreement With Oppenheimer & Co Inc   Benzinga
Sep 18, 2020
02:31PM EDT  Mid-Afternoon Market Update: Dow Tumbles 300 Points; COMPASS Pathways Shares Spike Higher   Benzinga
12:06PM EDT  Mid-Day Market Update: Nasdaq Turns Lower; Westport Fuel Systems Shares Surge   Benzinga
06:03AM EDT  A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Economic Data, Fed Speakers   Benzinga
Sep 17, 2020
04:06PM EDT  IsoRay Q4 EPS $(0.02) Misses $(0.01) Estimate, Sales $2.28M Miss $2.70M Estimate   Benzinga
04:05PM EDT  Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced financial results for the fiscal fourth quarter and full-year ended June 30, 2020.   GlobeNewswire Inc
04:04AM EDT  Earnings Scheduled For September 17, 2020   Benzinga
Sep 16, 2020
08:13AM EDT  Isoray to Present at the Oppenheimer Fall Healthcare Life Sciences   GlobeNewswire Inc
Aug 18, 2020
08:22AM EDT  GT Medical Technologies Announces Data Demonstrating Positive Local Control, Safety Outcomes With GammaTile Therapy For Large Brain Metastases   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC